Antidepressant treatments enhance plasticity and increase neurogenesis in the adult brain, but it has been unclear how these effects influence mood. We propose that, like environmental enrichment and exercise, antidepressant treatments enhance adaptability by increasing structural variability within the nervous system at many levels, from proliferating precursors to immature synaptic contacts. Conversely, sensory deprivation and chronic stress reduce this structural variability. Activitydependent competition within the mood-related circuits, guided by rehabilitation, then selects for the survival and stabilization of those structures that best represent the internal or external milieu. Increased variability together with competition-mediated selection facilitates normal function, such as pattern separation within the dentate gyrus and other mood-related circuits, thereby enhancing adaptability toward novel experiences.
Neuronal plasticity: growth and change The extrinsic and intrinsic milieu becomes represented in the structure and function of neuronal networks during development through neuronal plasticity. In adulthood, this representation is continuously optimized and modulated through plasticity and learning [1] . Plasticity occurs at several levels, from neurogenesis to the adjustment of synaptic weights, and modulates both the structure and function of neuronal networks (Figure 1 ). Changes in function of the nervous system are essentially always based on a structural change at some level (neuronal, synaptic, protein, or genomic structure) and it is therefore difficult to make clear distinctions between functional and structural plasticity.
Plasticity can be conceptualized as two distinct processes. First, structural variability is generated through the overproduction of immature neuronal structures, which occurs at many levels from newborn neurons to the outgrowth of filopodia (Figure 1) . Second, selective stabilization among the overproduced structures retains those that best represent the internal or external milieu [2] . Structural variability may be stochastic, although it may also be genetically tuned, but selection is an active process driven by neuronal activity that reflects both extrinsic and intrinsic stimuli. Activity-dependent selection guides the stabilization of functionally relevant neurons and connections by utilizing genes involved in survival and synaptogenesis, or it eliminates weakly or incoherently active structures through the use of genes that underlie apoptosis and pruning [1, 3] . The elimination of weakly active neurons and connections is critical for optimizing the signal-to-noise ratio in neuronal networks. Neuronal plasticity can be compared to auditions for a Broadway show: if many candidates audition, the production team can select an optimal performer for each role (and send those not suitable back home), but if only a few people show up, almost all have to be utilized regardless of their talent.
During the past few years, neuronal plasticity, and in particular adult neurogenesis, has been implicated in the beneficial effects of antidepressant drugs and electroconvulsive shock (ECS) treatment [4] [5] [6] [7] . However, it has remained unclear how plasticity and neurogenesis impact mood and anxiety-related behaviors.
Here, we provide a framework for how chronic antidepressant drug treatment and ECS might utilize neurogenesis and other forms of neuronal plasticity to influence mood. We argue that antidepressants, environmental enrichment, and exercise increase structural variability at various levels in the nervous system, thereby offering more substrates for the selection process (Figure 1) [7] . Conversely, sensory deprivation and chronic stress would reduce variability and impair adaptability. Whereas acute stress may promote variability and adaptation, chronic stress is considered maladaptive and is associated with a loss of neurons and synapses [8, 9] . Furthermore, stress may increase activity in certain brain regions, such as the amygdala and the mesolimbic dopaminergic system, leading to hypertrophy of these structures.
We argue that chronic antidepressant treatments and ECS act -at least in part -by utilizing a similar mechanism to increase adaptability and facilitate structural and functional reorganization in neuronal networks that have evolved to boost the effects of environmental enrichment, although the cellular and molecular mechanisms may be different. We further suggest that the effects of enrichment and antidepressant treatments that increase plasticity take place at many levels within neuronal networks (Figure 1 ). Because experience-guided selection constantly eliminates inactive structures, an increase or decrease in variability does not need to influence the mean number of these structures in the brain (like counting the number of actors of the final cast does not tell you how many have auditioned), which makes detecting such a change
